mibefradil trade name posicor pharmaceutical drug used treatment hypertension chronic angina pectoris nonselective calcium channel blocker voluntary pulled market ten months fda approval citing potential serious health hazards shown post release mechanism action mibefradil characterized selective blockade transient lowvoltageactivated ttype calcium channels longlasting highvoltageactivated ltype calcium probably responsible many unique propertiescitation needed june roche announced voluntary withdrawal drug market one year approval fda due potential drug interactions deadly may occur taken together drug article relating cardiovascular system stub help wikipedia expanding httpsenwikipediaorgwikimibefradil